Enantioselective bioanalysis of beta-blocking agents: Focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol
- 1 November 1993
- journal article
- review article
- Published by Wiley in Biomedical Chromatography
- Vol. 7 (6), 277-295
- https://doi.org/10.1002/bmc.1130070602
Abstract
The recent developments in enantioselective HPLC‐separation techniques are impressive and are driven by industrial and academic interests; thus there is for instance a high demand for developing stereoselective assays for chiral drugs in biological fluids. The beta‐blocking agents, which possess an amino‐ propanol‐ or ‐ethanol side chain with at least one chiral centre, represent one of the most intensively investigated groups of more than 40 drugs introduced world wide. Seven of the most popular beta‐blockers were chosen as representatives: atenolol; betaxolol; carvedilol; metoprolol; pindolol; propranolol; and sotalol, these span the whole range of lipophilicity to hydrophilicity (polarity). Enantioselective HPLC bioassays for these β‐blockers published so far, including techniques based on chiral derivatizing agents (CDAs), chiral stationary phases (CSPs) and chiral mobile phase additives (CMPAs) have been reviewed and documented in the light of general aspects together with pharmacokinetic and pharmacodynamic considerations. Copyright © 1993 John Wiley & Sons, Ltd.SCOPUS: ar.jinfo:eu-repo/semantics/publisheKeywords
This publication has 100 references indexed in Scilit:
- Rats with portacaval shunt as a potential experimental pharmacokinetic model for liver cirrhosis: Application to carvedilol stereopharmacokineticsChirality, 1993
- The chiral chromatographic separation of β-adrenoceptor blocking drugsJournal of Pharmaceutical and Biomedical Analysis, 1992
- Chiral drugs: An industrial analytical perspectiveJournal of Pharmaceutical and Biomedical Analysis, 1991
- High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 1991
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused heartsBasic Research in Cardiology, 1989
- Separation and quantitation of (R)‐ and (S)‐atenolol in human plasma and urine using an α1‐AGP columnChirality, 1989
- High Performance Liquid Chromatographic Determination of the Enantiomers of β-Adrenoceptor Blocking Agents in Biological Fluids I: Studies with PindololJournal of Pharmaceutical Sciences, 1986
- A rational approach to the design of highly effective chiral stationary phases for the liquid chromatographic separation of enantiomersJournal of Pharmaceutical and Biomedical Analysis, 1984